stempeucel
Cell therapyexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
0
Phase 4
2
Earliest trial started Feb 20, 2017 (NCT03056742)
Timeline
2010s
- Jan 1, 2017
Earliest Phase 2 Sponsor(trial)
Indications
Approved for
Mechanism of action
- Stem CellSupplementation
Stem Cell supplementation
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- stempeucel
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05854615 | Phase 4 | May 31, 2023 | Cell Biopeutics Resources Sdn Bhd, National University of Malaysia, Stempeutics Research Pvt Ltd |
| NCT05854641 | Phase 4 | May 31, 2023 | Cell Biopeutics Resources Sdn Bhd, National University of Malaysia, Stempeutics Research Pvt Ltd |
| NCT03056742 | Phase 2 | Feb 20, 2017 | Stempeutics Research Pvt Ltd |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Stempeutics Research Pvt Ltd | For profit | 3 | 1 | 2 | 2017 |
| Cell Biopeutics Resources Sdn Bhd | For profit | 2 | 2 | 1 | 2023 |
| National University of Malaysia | Academic/Hospital | 2 | 0 | 1 | 2023 |
3 organizations
Page 1 / 1